<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">Antiphospholipid syndrome</z:e> (APS) is an <z:e sem="disease" ids="C0004364" disease_type="Disease or Syndrome" abbrv="">autoimmune disorder</z:e> defined by the presence of characteristic clinical features and specified levels of circulating <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (Box 1 and Box 2) </plain></SENT>
<SENT sid="1" pm="."><plain>Diagnosis requires that at least one clinical and one laboratory criterion are met </plain></SENT>
<SENT sid="2" pm="."><plain>Because approximately 70% of individuals with APS are female (1), it is reasonably prevalent among women of reproductive age </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo> are a diverse group of antibodies with specificity for binding to negatively charged <z:chebi fb="1" ids="16247">phospholipids</z:chebi> on cell surfaces </plain></SENT>
<SENT sid="4" pm="."><plain>Despite the prevalence and clinical significance of APS, there is controversy about the indications for and types of antiphospholipid tests that should be performed in order to diagnose the condition </plain></SENT>
<SENT sid="5" pm="."><plain>Much of the debate results from a lack of well-designed and controlled studies on the diagnosis and management of APS </plain></SENT>
<SENT sid="6" pm="."><plain>The purpose of this document is to evaluate the data for diagnosis and treatment of APS </plain></SENT>
</text></document>